Zimmer Biomet releases fourth-quarter, full-year 2022 financial results
Click Here to Manage Email Alerts
Zimmer Biomet Holdings Inc. announced increased net sales from continuing operations in its fourth-quarter and full-year 2022 financial results, according to a company press release.
Zimmer Biomet reported net sales of $1.825 billion in the fourth quarter of 2022, a 2.7% increase from the prior year period. The company also reported net sales of $6.94 billion for the full year 2022, a 1.6% increase from 2021.
“We closed out the fourth quarter strong, driven by the solid execution of our team and meaningful innovation in our portfolio – all against a backdrop of continued recovery post-pandemic,” Bryan Hanson, chair, president and CEO of Zimmer Biomet, said in the release. “As we enter 2023, we expect macro pressures to continue, but also to stabilize, setting up [Zimmer Biomet] to achieve attractive growth and mark another key milestone in our transformation journey. We remain committed to building out our portfolio, delivering on our mission and creating value for all of our stakeholders,” Hanson added.
Read more about
Click Here to Manage Email Alerts